Susanne Andrea Gatz

13PUBLICATIONS
193CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsDisease surveillancePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Katie E Hebron, Patience Odeniyide, Yun Wei

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Jan 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Susanne A Gatz, Julia Glade-Bender, Andrew D J Pearson

|Nov 03, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma.

Francesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili

|Sep 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.

Antonio Juan Ribelles, Arthur Felix, Nuria Benavent

|Sep 05, 2025
Relapsed rhabdomyosarcoma: treatment recommendations from the European pediatric soft tissue sarcoma study group (EpSSG).

A S Defachelles, W B Breunis, M Casanova

Pageof 3

Frequent Collaborators

4 joint publications

Julia Chisholm

4 joint publications

Michael J F Hubank

4 joint publications

Louis Chesler

3 joint publications

Anne-Sophie Defachelles